Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 10 | uM | 9 | 2500.00 | 1434.95 | 2770.00 | 3812.75 | 0.7265 | 0.5944 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 3428.00 | 3812.75 | 0.8991 | 0.8547 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 2500.00 | 1434.95 | 1999.00 | 3812.75 | 0.5243 | 0.2651 |
| BT-20 | Erlotinib | 1 | uM | 9 | 2500.00 | 1434.95 | 2883.00 | 3812.75 | 0.7562 | 0.6403 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 2500.00 | 1434.95 | 4220.00 | 3812.75 | 1.1068 | 1.1493 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4125.00 | 3812.75 | 1.0819 | 1.1148 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 2500.00 | 1434.95 | 4191.00 | 3812.75 | 1.0992 | 1.1388 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 4136.00 | 3812.75 | 1.0848 | 1.1188 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 4062.00 | 3812.75 | 1.0654 | 1.0919 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 2500.00 | 1434.95 | 3740.00 | 3812.75 | 0.9809 | 0.9729 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4053.00 | 3812.75 | 1.0630 | 1.0886 | |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 2500.00 | 1434.95 | 4093.00 | 3812.75 | 1.0735 | 1.1032 |
| BT-20 | Erlotinib | 10 | uM | 9 | 2500.00 | 1434.95 | 2104.00 | 3812.75 | 0.5518 | 0.3119 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 2500.00 | 1434.95 | 3972.00 | 3812.75 | 1.0418 | 1.0589 |
| BT-20 | Lapatinib | 10 | uM | 9 | 2500.00 | 1434.95 | 1538.00 | 3812.75 | 0.4034 | 0.0504 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3872.00 | 3812.75 | 1.0155 | 1.0220 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3940.00 | 3812.75 | 1.0334 | 1.0471 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 2500.00 | 1434.95 | 3802.00 | 3812.75 | 0.9972 | 0.9960 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3782.00 | 3812.75 | 0.9919 | 0.9886 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3518.00 | 3812.75 | 0.9227 | 0.8891 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 3547.00 | 3812.75 | 0.9303 | 0.9001 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 2919.00 | 3812.75 | 0.7656 | 0.6548 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 1187.00 | 3812.75 | 0.3113 | -0.1259 |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 2500.00 | 1434.95 | 2070.00 | 3812.75 | 0.5429 | 0.2968 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 4121.00 | 3812.75 | 1.0808 | 1.1134 |